510(k) Cell Robotics Inc. LASETTE 12/03/03
DEC 2 2 2003 K. 033794
510(K) Summary
Cell Robotics’ Clinical Lasette P-200 Laser Skin Perforator

This 510(K) Summary of safety and effectiveness for the Cell Robotic's Clinical Lasette

P-200 Laser Skin Perforator is submitted in accordance with the requirements of the

SMDA 1990 and following guidance concerning the organization and content of a

510(K) summary.

Applicant: Cell Robotics, Inc.

Address: 2715 Broadbent Parkway NE
Albuquerque, NM 87107

Contact Person: Linda A. Blair, Assistant Quality Manager

Telephone: (505) 343-1131 Ext. 124
(505) 344-8112

Preparation Date: 12-3-03

Device Trade Name: Clinical Lasctte P-200

Common Name: Laser skin perforator

Classification: Class II

Legally Marketed Predicate Device: Cell Robotics, Inc. Lasette Plus

Description of the Cell Robotic's The Cell Robotics Lasette laser skin perforator is a

Lasette Laser Skin Perforator portable battery operated laser device. The device
produces a single pulse of laser light which ablates
a small hole in the patient's fingertip comparable to
that produced by commonly used stainless steel
blood lancets.

Intended use Ablation of skin for collecting capillary blood
samples for subsequent analysis.

Indications for use The Cell Robotic's Lasette Laser Skin Perforator is
indicated for use by qualified healthcare
professionals for the perforation of skin to draw
capillary blood for screening purposes.

Contraindications for Use The Lasette should not be used to collect samples
for use in analyzers that require complex sample
transfer procedures.

vil

510(k) Cell Robotics Inc. LASETTE 12/03/03
Nonclinical Performance Data: None
Clinical Performance Data: None
Conclusion: The Cell Robotic's Clinical Lasette P-200 Laser
Skin Perforator is substantially equivalent to the
predicate device.
Additional Information: None requested at this time
Vill

es
f & DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
B
* Food and Drug Administration
9200 Corporate Boulevard
DEC 2 2 2003 Rockville MD 20850
Ms, Linda A. Blair
Assistant Quality Manager
Cell Robotics, Inc.
2715 Broadbent Parkway NE, Suite A-E
Albuquerque, New Mexico 87107
Re: K033799
Trade/Device Name: Clinical Lasette P-200
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: December 3, 2003
Received: December 5, 2003
Dear Ms. Blair:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. ‘The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class [Il (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does noi mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Linda A. Blair
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

le iV M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure

INDICATION FOR USE STATEMENT
510(k) Number: K 03 / 4 4
Device Name: Lasette Laser Skin Perforator
Trade Name: _— Clinical Lasette P-200
Indications for Use:
The Cell Robotic's Clinical Lasette P-200 Laser Skin Perforator is
indicated for use by qualified healthcare professionals for the
perforation of skin to draw capillary blood for screening
purposes.
(Please do not write below this line - Continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
_ision Sie-Gry ,
~ sion of G.-crs}, Restorative
2 Neurologica, Devices
. Prescription Use_{/ OR Over-the-Counter Use
(per 21 CFR 801.109)
ix

